Use of the highly toxic and easily prepared rodenticide tetramethylenedisulfotetramine (TETS) was banned after thousands of accidental or intentional human poisonings, but it is of continued concern as a chemical threat agent. TETS is a noncompetitive blocker of the GABA type A receptor (GABA A R), but its molecular interaction has not been directly established for lack of a suitable radioligand to localize the binding site. We synthesized [ 14 C]TETS (14 mCi/mmol, radiochemical purity >99%) by reacting sulfamide with H 14 CHO and s-trioxane then completion of the sequential cyclization with excess HCHO. The outstanding radiocarbon sensitivity of accelerator mass spectrometry (AMS) allowed the use of [ neurotoxicity | convulsant | molecular modeling S evere poisonings in a German furniture factory in the 1940s were traced to wool impregnated with the resinous reaction product of sulfamide (NH 2 SO 2 NH 2 ) and formaldehyde (HCHO). The causative agent was identified as tetramethylenedisulfotetramine (TETS, also known as tetramine) which was then developed as a rodenticide (now illegal) and continues to be of concern as a chemical threat agent. The chronology of TETS chemistry and toxicology is given briefly here and more extensively in SI Appendix, section S1.
TETS was first synthesized more than 80 y ago (1) (2) (3) . Structureactivity studies showed that any structural modification greatly reduces the toxicity (4) . The need to understand the distribution and fate of TETS led to 14 C radiosynthesis in 1967 (5) by an undisclosed method, but the product was only 80% pure, limiting the interpretation of biological experiments. Analysis is achieved by liquid chromatography/MS (6) or when ultrahigh sensitivity is required and [ 14 C]TETS is available by accelerator mass spectrometry (AMS) (7) , as reported here.
TETS is highly toxic to mammals with an i.p. LD 50 of 0.11-0.22 mg/kg in mice and rats, leading to its use as a rodenticide until it was banned worldwide in the early 1990s (2, 8, 9) . However, it is still available illegally and responsible for accidental or intentional poisonings in China and other countries. The estimated lethal dose of 7-10 mg in adult humans coupled with its ease of synthesis and stability serve as the basis for the chemical threat concern (10) (11) (12) (13) (14) (15) . Neurotoxicity is sometimes alleviated or antidoted by compounds modulating the target site to reduce disruption by the toxicant. TETS toxicity is reported to be alleviated in rodents or humans by diazepam, barbiturates, allopregnanolone, and sodium 2,3-dimercapto-1-propanesulfonate (NaDMPS), some of which are GABA A R modulators (16) (17) (18) (19) (20) (21) (22) (23) (24) (SI Appendix, section S1). TETS is one of several small-cage convulsants, a group that also includes bicyclophosphorus compounds, such as the even more toxic t-butylbicyclophosphate (TBPO) and t-butylbicyclophosphorothionate (TBPS) (25) (Fig. 1) .
TETS is a noncompetitive antagonist of the GABA type A receptor (GABA A R) based on multiple physiological and toxicological criteria* (20, (26) (27) (28) (29) CHO (5 μmol, 3% in water, 250 μCi, specific activity 50 mCi/mmol, 99% pure by HPLC) at 0°C. The reaction mixture was slowly warmed to room temperature and stirred for 1 d. After adding acetonitrile (250 μL), the azeotrope was evaporated under a stream of dry air at room temperature. To the remaining reaction mixture were added 21 μL of conc. HCl and 3.8 μL of unlabeled HCHO (37% in water). After 1 h, acetonitrile (100 μL) was added and the azeotrope was again removed under a stream of dry air at room temperature. The remaining solid was dissolved by adding 100 μL of acetone then 500 μL of dichloromethane, yielding a white precipitate. After filtration, the filtrate was evaporated under a stream of dry air and the residual crude TETS was purified by column chromatography on silica gel with an eluent (dichloromethane: n-hexane 3:1, R f = 0.54). The [ 14 C]TETS was obtained on evaporation as a white solid: 310 μg, 12.9% chemical yield, 7.2% radiochemical yield, specific activity 14 mCi/mmol, and >99% radiochemical purity (SI Appendix, section S2). The product was dissolved in 1 mL acetone and stored in a sealed amber glass ampoule at −20°C. GC-MS analysis data for the final [ (Table 1) . C-labeled compound require an ultrasensitive analytical method provided by the use of tandem HPLC and AMS with a typical limit of quantification of 2-20 amol, which proved to be adequate in the present studies.
[ 14 C]TETS undergoes specific binding to rat brain membranes at 37°C with half saturation at 0.08 μM (Fig. 3A) . TETS is also a potent inhibitor of [ (Fig. 3B) (Fig. 3A) was considerably more potent than three of its analogs assayed with either radioligand. The TETS-type compounds (1-5) and several insecticides or cage convulsants (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (33) (34) (35) (36) (37) (38) (39) (40) . TETS, TBPO, and EBOB were initially molecularly docked in the pore region of the α 1 β 2 γ 2 GABA A R model. After 40 ns of molecular dynamics (MD) simulations (described in SI Appendix, section S5), their optimized and equilibrated positions ( Fig. 5 ) illustrate that EBOB and TBPO overlap the proposed TETS binding site (located around the 1′2′ region of the pore). MD stimulations of all of the insecticides and convulsants in this study predict a partially overlapping binding site with a common region at the 1′2′ position (the 2′ "contact zone") (SI Appendix, section S6). However, the interactions with specific residues in the 1′2′ position can differ. TETS and EBOB, for example, both make a substantial proportion of all their calculated contacts to the 1′2′ residues (61% and 45%, respectively). However, whereas EBOB contacts the α/γ subunits at the 1′2′ site 68% of the time (only slightly more than the 60% expected for nonspecific subunit binding), TETS contacts the α/γ subunits at the 1′2′ site 98% of the time with an α 1 :β 2 ratio of 31:1, suggesting a specific α 1 interaction. Moreover, 69% of all of the simulated TETS contacts with GABA A R are made to just the α 1 T1′ and γ 2 S2′ residues. In contrast, EBOB makes only 6% of its contacts to these residues. Extracting detailed interactions from our simulations posits four ways to interact with the 1′2′ residues (SI Appendix, section S7): specific polar interactions (TETS), both significant polar and hydrophobic interactions (TBPO and TBPS), general hydrophobic interactions (such as EBOB), and nonspecific or nonsignificant interactions that imply that other residues within the GABA A R pore are more important for binding (e.g., PTX interacts with 6′ as a key residue).
The predicted TETS and EBOB residue contact differences and binding interactions correspond with the sensitivity and specificity observed in expressed human β 3 (hydrophobic at 1′2′) homopentameric GABA A Rs (33) . In agreement with mutation studies that show that changes to the β 3 homopentameter 2′ residue from hydrophobic to polar (A→S) decreases the affinity of EBOB for the receptor (36, 37, 39) , our binding pattern shows EBOB makes significant hydrophobic interactions at the 1′2′ region during the simulation. Conversely, our simulated TETS makes polar interactions at this 1′2′ region, suggesting that polar residues are needed for TETS binding. In the β 3 subunit valine and alanine have replaced the α 1 T1′ and γ 2 S2′ residues, abolishing the necessary polar residues that TETS is predicted to bind, and could explain why α 1 β 2 γ 2 is sensitive to TETS but the homopentamer is not. Thus, a β 3 homopentamer 1′V→T or 2′ A→S mutant (similar to the α 1 or γ 2 residues) may show increased affinity for TETS. Cl uptake in membrane vesicles of the cerebral cortex (20, 32) . Type A compounds include EBOB and many insecticides with large substituents or extended structures, and the type B set includes TETS, TBPS, TBPO, and other small compact molecules, some of very high i.p. toxicity to mice (LD 50 36 μg/kg for TBPO) (25) (SI Appendix, section S8), although much less toxic to injected houseflies (LD 50 90 mg/kg for TETS) (4). The target site mapping studies above suggest a molecular distinction between the binding of type A compounds and Type B cage convulsants (32) . Type B antagonists (TETS, TBPO, and TBPS) bind with significant polar interactions, whereas type A antagonists (PTX, lindane, 12-ketoendrin, and EBOB) do not (SI Appendix, section S7). In confirmation, distinct differences appear between types A and B compounds on comparing native, α 1 β 3 γ 2 , and (β 3 ) 5 GABA A Rs (33) . Whereas the type A compounds are exceptionally potent on the β 3 homopentamer, the type B TBPS acts similarly on all three receptor types and TETS is a poor inhibitor of (β 3 ) 5 (33, 34) . Considering these relationships, we propose that the type B compact set including TETS and TBPS undergoes significant polar interactions in the 1′2′ ring, whereas the type A elongated compounds such as EBOB do not. Interestingly, the insecticidal activity of the isoxazoline fluralaner (10) seems to result from action at a distinct GABA receptor site (41, 42) not considered here.
TETS Candidate Antidotes. TETS was the first and because of many poisoning cases is now the best known of the small-cage convulsants, but some bicyclophosphorus compounds are much more toxic and probably act in the same way (19, 25) . After a half century of search, there are still no adequate antidotes for TETSinduced poisoning, either accidental or intentional. The candidates have come from anticonvulsants used to counteract convulsant action, trials in rats and mice, and mechanism studies in animals, cells, and in vitro systems (SI Appendix, section S1). Cell and nerve studies confirm action on GABA-induced signals and chloride flux. Diazepam and Na phenobarbital increase the mouse i.p. LD 50 of TETS by severalfold (19) (30) and alleviating TETS toxicity (11, 27, 28) . NaDMPS, a chelating agent normally used for treating heavy metal poisoning, is effective as a TETS antidote in rodent models and human poisonings proposed to be due to elevating GABA levels rather than as a chelator (SI Appendix, section S1). GABA levels are elevated by TETS poisoning in rats and GABA administration relieves the convulsions (SI Appendix, section S1). The seizures induced by acute and repeated exposure to TETS are characterized as actions at both GABA and NMDA receptors (28, 29) . TETS inhibition of NMDA-induced Ca 2+ signaling in cultured hippocampal neurons is partially reversed by either, or both, NaDMPS and allopregnanolone (28 , section S3 ). Baclofen at 1 μM and ethanol at 300 mM had apparently somewhat different effects with the two radioligands (SI Appendix, section S3). However, TETS poisoning cases in humans have been treated with diazepam, allopregnanolone, and NaDMPS with little or no benefit (9) (10) (11) (12) (13) (14) (15) .
The GABA A R is the target of many toxicants for mammals (TETS) and insects (insecticides) and exists in a multiplicity of subunit and interface combinations (43, 44), allowing high toxicity that reaches its extreme for mammals with TETS and some other small-cage convulsants. In the search for antidotes the GABA A R in vitro assays described here may provide a rapid means of limiting the number of compounds for animal experimentation and ultimate testing in cases of human poisoning. (6) , and EBOB following 40 ns of MD simulation in the pore region of the α 1 β 2 γ 2 GABA A R model, with views from the side (Left, the front two M2 helices have been removed for clarity), and views from the bottom of the pore (Right). The red dashed lines signify the common binding region around the 2′ "contact zone." The contact zone is the region where a compound can make contacts to 2′, either from above or below the residue. The view down the pore shows that at the 1′2′ region, TETS makes primarily polar interactions to the α and γ subunits (hydrogen bonds shown as dashed magenta lines), TBPO makes both polar and hydrophobic interactions, and EBOB makes nonspecific hydrophobic interactions with this 1′2′ ring of residues.
Cartridges (Super Spe-ed silica gel, 5101; Applied Separations). Radioactivity was determined by liquid scintillation analysis using a Tri-Carb 2810 TR. GC-MS data were recorded on a HP 6890 GC with the 5973 MS instrument.
GABA A R Membrane Preparation. The preparation method was modified from that of Squires et al. (30) . Whole rat brains from Pel-Freez Biologicals stored at −80°C were thawed and homogenized in 50 volumes of ice-cold 1 mM EDTA using a Brinkmann Polytron Homogenizer. The homogenate was centrifuged at 1,000 × g for 10 min, and the supernatant was then centrifuged at 25,000 × g for 30 min. The resulting pellets were suspended in 50 volumes of 1 mM EDTA, packed into cellophane tubing, and dialyzed against distilled/deionized water in an ice-bath (1-2 L, three times for 2 h). The dialyzed suspension was then centrifuged at 25,000 × g for 30 min and the pellets were stored at −80°C.
Binding Assays. The rat brain membrane pellets from storage at −80°C were suspended in ice-cold buffer B [10 mM phosphate buffer (pH 7
14 C]TETS in 1.0 mL of buffer B. After incubation with shaking for 90 min at 37°C, the mixtures were filtered through GF/C filters and rapidly rinsed three times with 5 mL of cold buffer B using a Brandel M-24 cell harvester. Tritium from bound [ 3 H]EBOB was quantitated by liquid scintillation counting (31) . Rabiocarbon from [
14 C]TETS was analyzed by AMS. The filter papers were collected, put in Eppendorf tubes, and held up to 4 wk at 4°C. Then, each filter loaded with protein was placed with 1 μL tributyrin carbon carrier in a quartz tube (∼6 × 30 mm, 4 mm i.d.) nested inside two borosilicate glass culture tubes (10 × 75 mm in 12 × 100 mm) and dried overnight in a vacuum centrifuge. An excess of CuO (∼40 mg) was added and the inner quartz vials were transferred to quartz combustion tubes, evacuated, and sealed with a torch. The samples were combusted at 900°C for 3.5 h to oxidize all organic carbon to CO 2 and then reduced to filamentous carbon as previously described (46). Carbon samples were packed into aluminum sample holders, and carbon isotope ratios were measured on the compact 1-MV AMS spectrometer at the Lawrence Livermore National Laboratory. Typical AMS measurement times were 3-5 min per sample, with a counting precision of 0.6-1.4% and a SD among 3-10 measurements of 1-3%. The 14 C/ 13 C ratios of the protein samples were normalized to measurements of four identically prepared standards of known isotope concentration (IAEA C-6, also known as ANU sucrose) and converted to units of femtograms TETS per microgram protein (47). Each experiment was performed in triplicate and repeated three times in determining the mean and SEs. Curve fitting used the nonlinear (Fig. 3) or linear (Fig. 4) regression program with Prism Software Version 5.0 (GraphPad Software Inc.).
Modeling the GABA A R Binding Sites. The GABA A R α 1 β 2 γ 2 homology model was built with a GluCl template (PDB ID code 3RHW) (48) using previously published protocols (36, 37) . Small molecules were parameterized with the PRODRG server (49) and docked into the pore using VinaLC (50). The proteinligand system was embedded in a lipid bilayer and solvated. Atomistic simulations were performed using GROMACS (51). For more details, see SI Appendix, section S5. 
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Wood FC ,Battye AE (1933) The condensation of sulphamide, dimethylsulphamide, and aniline-p-sulphonamide with formaldehyde. J Soc Chem Ind 56:346-349. (14), fipronil (15) , and -endosulfan (16)). Each system had the compound molecularly docked into the pore using VinaLC (4). The ligands were prepared for docking using MGLTools (5, 6). The docking was performed on 30x30x30 Å grid with 0.33 Å resolution that was centered on the pore region to examine potential binding sites at this vicinity. Twelve exhaustiveness docking runs were carried out per compound. Any water molecules in the pore that overlapped the small compound were removed, and the system was again energy minimized. The ligand-bound, membrane-embedded protein system was then subjected to 40 ns MD simulation production to identify the equilibrated ligand position and the protein-ligand interactions.
All MD simulations were run using GROMACS 4.5.5 (7). The Berger et al. force field was used for the POPC molecules (8), the gromos53a6 force field was used for the protein and the small compounds (9) . The parameters for the small compounds were generated using the PRODRG server (10). The SPC model was used to represent the water (11) . Simulations were performed at 323 K using the Nosé-Hoover thermostat (12) with τT = 0.5 ps. The pressure was maintained at 1 bar using a semi-isotropic Parrinello-Rahman barostat (13) with τP = 1 ps and a compressibility of 4.5x10 -5 bar -1 . Bonds lengths were constrained using the LINCS algorithm (14) , allowing a 2-fs time step to be used. Non-bonded interactions were truncated at 14 Å, and the neighbor list updated every 10 ps. The long-range electrostatic interactions were calculated using the particle mesh Ewald method (15) . Images were prepared and analyses were carried out using GROMACS, locally written scripts, and VMD (16). The results of classifying the compounds in the different quadrants are consistent with previously published data on compound binding to specific subunit configurations. In general, TETS (Q4) requires polar interactions for binding and explains why the TETS binding is abolished in the 3 homopentamer (where all the 1'2' residues are hydrophobic [1] ). TBPO and TBPS, like TETS, also require polar interactions. However, hydrophobic interactions are also required for TBPO and TBPS binding. The requirement of having both hydrophobic and hydrophilic residues in the 1'2' ring is consistent with TBPS only binding significantly when both  and  subunit subtypes make up the GABAAR. [2, 3] BIDN (and to a lesser extent EBOB) relies on mainly hydrophobic interactions at this region. BIDN binding to the insect RDL receptor is reduced when hydrophobic A2' is mutated to polar S2' [4] , showing the need for hydrophobic residues for binding. EBOB also has its binding reduced when A2' is mutated to S2' in the 3 homopentamer, though it appears that the more crucial interaction is outside of the 1'2' ring at the 6' residue [5] . Hence, the 1'2' percentage hydrophobic contacts are lower for EBOB than BIDN. As the compounds in Q3 do not appear to make large percentage contacts to either polar or hydrophobic residues, we hypothesize that their major interactions with the GABAAR pore take place outside of the 1'2' ring. This is true for PTX, which has interactions with 6' [6] . However, several of the Q3 compounds are greatly extended in length and make interactions with two, if not three, of the pore-lining rings of M2 residue. Furthermore, the two established types of cage convulsants [7] ('elongated' Type A, and 'compact' Type B) fall into two distinct categories (S8). Type A convulsants are shown in blue, and Type B are shown in red. While both Type A and Type B cage convulsants may act at a similar site within the pore, Type B compounds make a significant number of polar interactions, and Type A compounds do not.
